Pharmafile Logo

Cuttsy+Cuttsy awarded CPD Platinum by the IPA

Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation.

- PMLiVE

Platinum is only awarded to agencies who have reached gold level four years out of five and C+C have done it in their first four years of full membership of the IPA. In 2018 the agency team completed 905 hours of professional development vs. the 333 hours that agency needed to meet the IPA standard requirements.

On receiving the news Mathew Cutts, Co-Founder and Director spoke about the importance of the award ‘The workplace is evolving very quickly and attracting and retaining great people is no longer just about salary and a bonus. People are looking for many different aspects of employment, such as flexible working, having a career that makes a difference, progression and of course the chance to learn. This award is testament to the team and their thirst to want to continually improve it also evidences our commitment to the growth of individuals as well as the company’.

Kate McCabe, HR manager who is responsible for the initiative talked about what it takes to become a Platinum award winner. ‘Hard work and dedication, but more importantly, a commitment to truly investing in the belief that developing your team will not only develop and grow the business but motivate and retain the best people. Ultimately, providing a first-class service to your clients and for us most importantly, patients.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Designing with patients in mind: How to build more inclusive clinical trials

Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.

Why fresh patient voices are critical to improve clinical trials outcomes

Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost recruitment, retention, and patient-centric research.

Using patient personas to add a personal touch to clinical trial recruitment and retention

Discover how patient personas can revolutionise clinical trial recruitment and retention. Personalise outreach, build trust, and improve patient engagement.

A month of insights: Key takeaways from May’s conferences

Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, and tech innovation shaping clinical trials.

Cuttsy+Cuttsy and ISPEP highlight key patient insights in new clinical trials report

Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.

Motivations that matter: Understanding clinical trial participation to create better research

Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores the diverse motivations driving participation — from altruism and hope for better health to...

Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning

Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.

AI and away we go: key insights from Reuters Pharma 2025

AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications across marketing, drug discovery, and patient engagement, despite challenges in adoption, regulation, and data trust.

Exciting updates from our content and strategy team

Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.

How is generative AI transforming clinical trials?

Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis.